143 related articles for article (PubMed ID: 12221661)
1. Homocysteine in neuropsychiatric disorders of the elderly.
Reutens S; Sachdev P
Int J Geriatr Psychiatry; 2002 Sep; 17(9):859-64. PubMed ID: 12221661
[TBL] [Abstract][Full Text] [Related]
2. The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller AL
Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
[TBL] [Abstract][Full Text] [Related]
3. [Homocysteine and dementia].
Kessler H; Bleich S; Falkai P; Supprian T
Fortschr Neurol Psychiatr; 2003 Mar; 71(3):150-6. PubMed ID: 12624852
[TBL] [Abstract][Full Text] [Related]
4. [Homocysteine and neuropsychiatric disorders].
Sachdev P
Braz J Psychiatry; 2004 Mar; 26(1):50-6. PubMed ID: 15057841
[TBL] [Abstract][Full Text] [Related]
5. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
Barone P; Burn DJ; van Laar T; Hsu C; Poewe W; Lane RM
Mov Disord; 2008 Aug; 23(11):1532-40. PubMed ID: 18581467
[TBL] [Abstract][Full Text] [Related]
7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
8. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
[TBL] [Abstract][Full Text] [Related]
9. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
[TBL] [Abstract][Full Text] [Related]
10. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
Herrmann W; Lorenzl S; Obeid R
Fortschr Neurol Psychiatr; 2007 Sep; 75(9):515-27. PubMed ID: 17729191
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine and cognitive function.
Troen A; Rosenberg I
Semin Vasc Med; 2005 May; 5(2):209-14. PubMed ID: 16047273
[TBL] [Abstract][Full Text] [Related]
13. Significance of hyperhomocysteinemia.
Herrmann W
Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.
O'Suilleabhain PE; Sung V; Hernandez C; Lacritz L; Dewey RB; Bottiglieri T; Diaz-Arrastia R
Arch Neurol; 2004 Jun; 61(6):865-8. PubMed ID: 15210523
[TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine as a biomarker for cognitive dysfunction in the elderly.
Schulz RJ
Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):718-23. PubMed ID: 18089953
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people.
Dufouil C; Alpérovitch A; Ducros V; Tzourio C
Ann Neurol; 2003 Feb; 53(2):214-21. PubMed ID: 12557288
[TBL] [Abstract][Full Text] [Related]
19. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease.
Guidi I; Galimberti D; Lonati S; Novembrino C; Bamonti F; Tiriticco M; Fenoglio C; Venturelli E; Baron P; Bresolin N; Scarpini E
Neurobiol Aging; 2006 Feb; 27(2):262-9. PubMed ID: 16399211
[TBL] [Abstract][Full Text] [Related]
20. Conceptualization of mild cognitive impairment: a review.
Davis HS; Rockwood K
Int J Geriatr Psychiatry; 2004 Apr; 19(4):313-9. PubMed ID: 15065223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
